Alivus Life Sciences informs about board meeting

23 Jan 2025 Evaluate

Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, Alivus Life Sciences has informed that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2024. The said meeting of the Board commenced at 12:30 pm and concluded at 2:10 pm. The copy of the said results and Limited Review Report of the Auditors is enclosed. These are also being made available on the website of the Company at www.alivus.com.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

1099.50 32.70 (3.07%)
28-Mar-2025 10:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...